Ferrer Internacional, S.A. Kwizda Pharmadistribution GmbH
PolandAll drugs from this manufacturer
-
The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 1 mg/ml ATC: B01AC21
-
The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 2.5 mg/ml ATC: B01AC21
-
It is used in the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, and facilitates oxygen uptake by the body.
Dosage form: solution for infusion
Active substance Dosage treprostinil 5 mg/ml ATC: B01AC21
-
The medicinal product is used in the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 10 mg/ml ATC: B01AC21